EMILIN1 and neoplasm: A substantial decrease of EMILIN-1 expression was observed in carcinomas of the bladder, lung, ovary, rectum and uterus respect to the normal tissues (Fig. 6A), suggesting that the EMILIN-1 tumor-suppressive function may be lost in a broad spectrum of cancers.